These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 1922654
1. [Can cisplatin renal toxicity be prevented?]. Brillet G, Deray G, Bunker D, Ben Hmida M, Baumelou A, Jacobs C. Nephrologie; 1991; 12(3):143-6. PubMed ID: 1922654 [Abstract] [Full Text] [Related]
2. [Renal protection with amifostine during intraoperative peritoneal chemohyperthermia (IPCH) with cisplatin (CDDP) for peritoneal carcinosis. Phase 1 study]. Vaira M, Barone R, Aghemo B, Mioli PR, De Simone M. Minerva Med; 2001 Aug; 92(4):207-11. PubMed ID: 11535965 [Abstract] [Full Text] [Related]
3. Methods of reduction of cisplatin nephrotoxicity. Walker EM, Gale GR. Ann Clin Lab Sci; 1981 Aug; 11(5):397-410. PubMed ID: 6277229 [Abstract] [Full Text] [Related]
4. [New treatments for urogenital toxicity of anti-neoplastic chemotherapy]. Shibuya M, Hirosawa A, Niitani H. Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):950-6. PubMed ID: 2111664 [Abstract] [Full Text] [Related]
5. Renal complications of cis-diamminedichloroplatinum. Nitschke R. Ann Clin Lab Sci; 1981 Apr; 11(5):392-6. PubMed ID: 7199273 [Abstract] [Full Text] [Related]
6. [Experimental studies on the nephrotoxicity of cisplatin--amelioration of nephrotoxicity by continuous infusion]. Izumi T. Hinyokika Kiyo; 1988 Jan; 34(1):37-45. PubMed ID: 3132030 [Abstract] [Full Text] [Related]
7. Comparison of preventive effects of combined furosemide and mannitol versus single diuretics, furosemide or mannitol, on cisplatin-induced nephrotoxicity. Takagi A, Miyoshi T, Hayashi T, Koizumi H, Tsumagari K, Yokota C, Nakano T, Matsuo K, Egawa T. Sci Rep; 2024 May 07; 14(1):10511. PubMed ID: 38714773 [Abstract] [Full Text] [Related]
8. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Ali BH, Al Moundhri MS. Food Chem Toxicol; 2006 Aug 07; 44(8):1173-83. PubMed ID: 16530908 [Abstract] [Full Text] [Related]
9. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial. Santoso JT, Lucci JA, Coleman RL, Schafer I, Hannigan EV. Cancer Chemother Pharmacol; 2003 Jul 07; 52(1):13-8. PubMed ID: 12719883 [Abstract] [Full Text] [Related]
10. [Usefulness of oral rehydration solution for hydration in cancer chemotherapy: toward the application of outpatient chemotherapy with high-dose Cisplatin therapy-]. Sato J, Kudo K, Hino K, Takahashi K. Gan To Kagaku Ryoho; 2011 Sep 07; 38(9):1471-6. PubMed ID: 21918344 [Abstract] [Full Text] [Related]
11. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Launay-Vacher V, Rey JB, Isnard-Bagnis C, Deray G, Daouphars M, European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother Pharmacol; 2008 May 07; 61(6):903-9. PubMed ID: 18317762 [Abstract] [Full Text] [Related]
15. Hydration regimen and hematological toxicity of a cisplatin-based chemotherapy regimen. Clinical observations and pharmacokinetic analysis. Numico G, Benasso M, Vannozzi MO, Merlano M, Rosso R, Viale M, Esposito M. Anticancer Res; 1998 May 07; 18(2B):1313-8. PubMed ID: 9615808 [Abstract] [Full Text] [Related]
20. Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial. Murakami E, Akamatsu H, Shimokawa T, Wada K, Yamamoto N. BMJ Open; 2019 Dec 11; 9(12):e029057. PubMed ID: 31831529 [Abstract] [Full Text] [Related] Page: [Next] [New Search]